Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 523-528

  Brosnihan, K Bridget ^a   Li, Ping ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin peptides; coronary artery; endothelium derived relaxing factors; kinin; nitric oxide; prostaglandins

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 THREONINE]; ANGIOTENSIN[1-7]; CANDESARTAN; ENDOTHELIUM DERIVED RELAXING FACTOR; ICATIBANT; INDOMETACIN; N(G) NITROARGININE; NITRIC OXIDE; THROMBOXANE A2 DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; DOG; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0029926375     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.523     Document Type: Conference Paper

References (41)

1. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallant EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991;18(suppl III):III-126-III-133.
2. Fitzsimons JT. The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol. 1971;214:295-303.
3. Peach MJ, Chiu BA. Stimulation and inhibition of aldosterone biosynthesis in vitro by angiotensin II and analogs. Circ Res. 1974; 35,36(suppl I):I-7-I-13.
4. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo neurohypophysial system by the angiotensin (1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85:4095-4098.
5. Jaiswal N, Diz DI, Tallant EA, Khosla MC, Ferrario CM. Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells. Am J Physiol. 1991;260:R1000-R1006.
6. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
7. Moriguchi A, Tallant EA, Matsumura K, Reilly TM, Walton H, Ganten D, Ferrario CM. Opposing actions of angiotensin-(1-7) and angiotensin II in the brain of transgenic hypertensive rats. Hypertension. 1995;25:1260-1265.
8. Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1-7). Peptides. 1993;14:679-684.
9. Meng W, Busija DW. Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles. Stroke. 1993;24:2041-2045.
10. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 1993;234: 35-42.
11. Benter IF, Ferrario CM, Morris M, Diz DI. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol. 1995;269(Heart Circ Physiol):H313-H319.
12. Brosnihan KB, Santos RAS, Block CH, Schiavone MT, Welches WR, Chappell MC, Khosla MC, Greene LJ, Ferrario CM. Biotransformation of angiotensins in the central nervous system. Ther Res. 1988;9:48-59.
13. Ferrario CM, Chappell MC. A new myocardial conversion of angiotensin I. Curr Opin Cardiol. 1994;9:520-526.
14. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin-(1-7) in the spontaneously hypertensive rat. Peptides. 1993;14:883-891.
15. Santos RAS, Brosnihan KB, Jacobsen DW, DiCorleto PE, Ferrario CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension. 1992;19(suppl II):II-56-II-61.
16. Campbell DJ, Kladis A, Duncan AM. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension. 1994;23:439-449.
17. Chappell MC, Tallant EA, Brosnihan KB, Ferrario CM. Conversion of angiotensin I to angiotensin-(1-7) by thimet oligopeptidase (EC 3.4.24.15) in vascular smooth muscle cells. J Vasc Med Biol. 1994;5:129-137.
18. Sardinia MF, Hanesworth JM, Krebs LT, Harding JW. AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides. Peptides. 1993;14:949-954.
19. Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW. Elucidation of a specific binding site for angiotensin II (3-8), angiotensin IV, in mammalian heart membranes. J Pharmacol Exp Ther. 1993;266:1036-1042.
20. Mizuno K, Niimura S, Tani M, Saito I, Sanada H, Takahashi M, Okazaki K, Yamaguchi M, Fukuchi S. Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats. Life Sci. 1992;51:18.3-187.
21. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) [Ang-(1-7)] inhibits vascular smooth muscle cell growth. Hypertension. 1993;22:414. Abstract.
22. Porsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
23. Benter IF, Ferrario CM, Morris M, Diz D. Chronic intravenous angiotensin-(1-7) infusions activate antihypertensive mechanisms in spontaneously hypertensive rats. Am J Hypertens. 1994;7:94A. Abstract.
24. Nakamoto H, Ferrario CM, Fuller SB, Robaczwski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
25. Paula RD, Lima CV, Khosla MC, Santos RAS. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension. 1995;26:1154-1159.
26. Heyne N, Beer W, Muhlbauer B, Osswald H. Renal response to angiotensin-(1-7) in anesthetized rats. Kidney Int. 1995;47:975-976.
27. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313-370.
28. Erdos EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension. 1992;16:363-370.
29. Campbell DJ, Kladis A. Duncan AM. Bradykinin peptides in kidney, blood, and other tissues of the rat. Hypertension. 1993;21: 155-165.
30. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides: characterization of receptors. Hypertension. 1992;19(suppl II):II-49-II-55.
31. Andreatta-Van Leyen S, Romero MF, Khosla MC, Douglas JG. Modulation of phospholipase A2 activity and sodium transport by angiotensin-(1-7). Kidney Int. 1993;44:932-936.
32. Wiemer G, Scholkens BA, Busse R, Wagner A, Heitsch H, Linz W. The functional role of angiotensin II - subtype AT2 - receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett. 1993;3:24-27.
33. Illiano S, Mombouli JV, Nagao T, Vanhoutte PM. Potentiation by trandoloprilat of the endothelium-dependent hyperpolarization induced by bradykinin. J Cardiovasc Pharmacol. 1995;23:S6-S10.
34. Schror K. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J Cardiovasc Pharmacol 1995;20:S68-S73.
35. Feletou M, Germain M, Teisseire B. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro. Am J Physiol. 1992;262(Heart Circ Physiol):H839-H845.
36. Cowan CL, Cohen RA. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses. Am J Physiol. 1991;261(Heart Circ Physiol):H830-H835.
37. Hecker M, Dambacher T, Busse R. Role of endothelium-derived bradykinin in the control of vascular tone. J Cardiovasc Pharmacol. 1992;20:S55-S61.
38. Weintraub NL, Stephenson AH, Sprague RS, McMurdo L, Lonigro AJ. Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension. 1995;26:684-690.
39. Weintraub NL, Sprague RS, Stephenson AH, McMurdo L, Lonigro AJ. Bradykinin stimulates endothelium-derived hyperpolarizing factor production in porcine coronary artery through phospholipase C-induced activation of phospholipase A2. Hypertension. 1995; 26:567. Abstract.
40. Santos RAS, Brum J, Brosnihan KB, Ferrario CM. The renin-angiotensin system during acute myocardial ischemia in dogs. Hypertension. 1990;15(suppl I):I-121-I-127.
41. Campbell DJ, Kladis A, Duncan AM. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension. 1993;22: 513-522.